Age-related Macular Degeneration: The Silent Vision Killer

eye human

Age-related macular degeneration (AMD) is a common eye condition that affects millions of people around the world. It is a leading cause of vision loss in people aged 50 years and above. Despite its prevalence, many are still uninformed about this disease and its consequences.

AMD affects the macula, a small portion of the retina responsible for sharp, detailed vision. The disease gradually damages the macula, leading to blurred or distorted vision in the central part of the visual field. This makes simple tasks, such as reading or driving, difficult to accomplish.

AMD can be classified into two types: dry AMD and wet AMD. Dry AMD is the more common form and is characterized by a gradual loss of vision due to the thinning of the macula. Wet AMD, on the other hand, is caused by the growth of abnormal blood vessels that leak into the macula, affecting its function.

There are several risk factors that increase the likelihood of developing AMD, including age, smoking, high blood pressure, and a family history of the disease. Although there is no cure for AMD, there are treatment options that can slow its progression and preserve vision.

One of the best ways to prevent AMD is through early detection and regular eye exams. Doctors may perform tests such as a dilated eye exam, visual acuity test, or optical coherence tomography to diagnose AMD.

Dr. Kevin Dolan of 2020 Vision in Rochester Hills, MI, is an experienced optometrist who specializes in the treatment of AMD. He offers comprehensive eye exams and the latest diagnostic and therapeutic treatments for AMD. Dr. Dolan works closely with patients to develop a personalized treatment plan that addresses their individual needs and goals.

If you or a loved one is at risk of AMD or experiencing symptoms, it is crucial to seek professional help immediately. Don’t let AMD become a silent vision killer. Call 248-375-0040 to schedule an appointment with Dr. Dolan today.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *